Alejandro Donoso F.

Alejandro Donoso F.

Auto-generated profile, based on publicly available information

Alejandro Donoso F.

Hospital Padre Hurtado, Santiago, Chile

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
ADAlejandro F. Donoso
Alejandro F. Donoso
PCPablo I. Cruces
Pablo I. Cruces
JCJorge F. Camacho
Jorge F. Camacho
JLJosé A. León
José A. León
JKJorge A. Kong
Jorge A. Kong
Severe pertussis has a high mortality risk, especially in those with high white blood cell counts and pulmonary hypertension. Exchange transfusion can reduce the leukocyte mass in blood. We report 3 young infants with severe pertussis and hyperleukocytosis who developed cardiogenic shock and pulmonary hypertension. Exchange transfusion was performed. The white blood cell count decreased accompanied by improvement in the cardiopulmonary condition and survival in the 3 infants. Exchange transfusion should be considered in patients with severe pertussis with hyperleukocytosis.

1 February 2005 in Scandinavian Journal of Infectious Diseases
Verified
Journal Article
Closed access
ADAlejandro Donoso
Alejandro Donoso
JLJosé León
José León
MRMilena Ramírez
Milena Ramírez
GRGloria Rojas
Gloria Rojas
BOBernd Oberpaur
Bernd Oberpaur
Fatal myocardial failure secondary to pulmonary hypertension is reported in 5 young infants who presented with Bordetella pertussis infection. All cases showed severe leukocytosis. Three of the 5 patients died early despite intensive management. The autopsy revealed signs of pulmonary hypertension. In addition to acquiring further knowledge of its pathogenesis, it is necessary to develop some new therapeutic approaches to Bordetella pertussis infection in susceptible populations.

18 October 2011 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
PCPablo Cruces
Pablo Cruces
FDFranco Díaz
Franco Díaz
APAlonso Puga
Alonso Puga
BEBenjamín Erranz
Benjamín Erranz
ADAlejandro Donoso
Alejandro Donoso
GRGabriela M Repetto
Gabriela M Repetto

1 June 2012 in Revista chilena de infectología
Verified
Journal Article
Open access
PDF file
ADAlejandro Donoso
Alejandro Donoso
DADaniela Arriagada
Daniela Arriagada
PCPablo Cruces
Pablo Cruces
FDFranco Díaz
Franco Díaz

25 August 2008 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
ADAlejandro F. Donoso
Alejandro F. Donoso
JLJosé A. León
José A. León
JCJorge F. Camacho
Jorge F. Camacho
PCPablo I. Cruces
Pablo I. Cruces
MFMarcela Ferrés
Marcela Ferrés

1 December 2003 in Pediatric Emergency Care
Verified
Journal Article
Closed access
ADAlejandro Donoso
Alejandro Donoso
MLMarcela Linares
Marcela Linares
JLJosé León
José León
GRGloria Rojas
Gloria Rojas
CVCristián Valverde
Cristián Valverde
BOBernd Oberpaur
Bernd Oberpaur
Activated charcoal is useful in the management of poisonings, but it is not harmless. We report the case of a patient who developed obstructive laryngitis secondary to aspiration of activated charcoal with a protected airway. A 2-year-old girl presented acute mental alteration secondary to presumed poisoning. Mechanical ventilation was initiated, and a single dose of activated charcoal was administered. She had an episode of vomiting during the respiratory weaning. Black-tinted tracheal secretions were suctioned through the tube immediately. Pulmonary auscultation and radiologic examination were normal. When she was extubed, she developed obstructive laryngitis. Fiberbronchoscopy was performed and showed edema and a significant amount of charcoal particles on the epiglottis, arytenoids, and arytenoepiglottic folds. Charcoal particles were removed by bronchoscopy successfully. Later evolution was normal, and no symptoms were present when she was discharged at home. Obstructive laryngitis is a new major complication of activated charcoals use in upper airway. It is remarkable that this complication occurred in a protected airway. Charcoal is not an innocuous agent. This case shows that nasogastric administration of activated charcoals presents a significant degree of risk.